Search
×
FR

Placeholder headline

This is just a placeholder headline

API Technical Report TDB-6 Chapter 6 – Density

$

204

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 560: Fired Heaters for General Refinery Services

$

721

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 64: Diverter Equipment Systems

$

324

BUY NOW

Placeholder headline

This is just a placeholder headline

API MPMS CH 17.10.1: Refrigerated Light Hydrocarbon Fluids – Measurement of Cargoes on Board LNG Carries

$

417

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 13B-1: Testing Water-based Drilling Fluids

$

418

BUY NOW

Placeholder headline

This is just a placeholder headline

API Technical Report TDB-12 Chapter 12 – Thermal Conductivity

$

214

BUY NOW

Placeholder headline

This is just a placeholder headline

API 16FI Frac Iron Guidelines and Requirements

$

129

BUY NOW

ISO 17822:2020

ISO 17822:2020 In vitro diagnostic test systems – Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens – Laboratory quality practice guide

CDN $312.00

SKU: c56685d4e56c Categories: ,

Description

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.

Edition

1

Published Date

2020-12-01

Status

PUBLISHED

Pages

39

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.

Previous Editions

Can’t find what you are looking for?

Please contact us at: